Psychedelics Archives - Page 40 of 68

2 minute read

MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production

March 2, 3:50 PM

PharmAla To Be Exclusive MDMA Supply Partner To Awakn Life Sciences Effective immediately, MDXX class molecules producer PharmAla Biotech Holdings Inc. will become the exclusive MDMA supplier to Awakn Life Sciences (OTCMKTS: AWKNF).

AWKNF

2 minute read

Braxia Scientific’s Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals

By Lara Goldstein

March 2, 3:26 PM

Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.

BRAXF

2 minute read

Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program

By Lara Goldstein

March 1, 10:30 PM

Canadian clinical-stage psychedelics developer Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) will start trading its Class A common shares following a 4-to-1 stock split towards increasing liquidity.

AGNPF

1 minute read

Lucy Scientific Secures First Delivery Of Psilocybin To Israel Following DMT & 5-MeO-DMT

By Lara Goldstein

February 28, 6:29 PM

Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Canada-based psychedelics manufacturing company, has inked its first commercial sale to the prestigious Hadassah BrainLabs, also known as the Center for Psychedelics Research at the Hadassah Medical Center at Hebrew University in Jerusalem.

LSDI

2 minute read

COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials

By Lara Goldstein

February 28, 3:55 PM

Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress. Numbers show:

CMPS

2 minute read

Shark Tank’s Kevin Harrington Will Provide Strategic Guidance To Major Psychedelics Company

By Lara Goldstein

February 28, 3:29 PM

Psychedelics biopharma company FSD Pharma Inc. (NASDAQ: HUGE)’s advisory board has a new member: the iconic entrepreneur and inventor of the infomercial Kevin Harrington.

HUGE

5 minute read

Psyched: Hawaii And Minnesota’s Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry’s Future And More

By Lara Goldstein

February 27, 8:28 PM

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and psilocybin as an alternative to treat mental health conditions.

AGNPF

3 minute read

Red Light Holland’s Q3 2023 Financials: Expanded Farms Division, Home Grow Kits & Revenue Increase

By Lara Goldstein

February 27, 2:10 PM

Ontario-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its interim financial results for the third fiscal quarter of 2023 -three and nine months- ended December 31, 2022.

TRUFF

2 minute read

Cybin Restructures Staff As It Enters Clinical-Stage Era: Here’s How The Market Responded

By Nina Zdinjak

February 23, 12:17 PM

Cybin Inc. (NEO:CYBN) (AMEX:CYBN) announced Thursday a streamlining plan aimed at maximizing the company’s operating efficiency and allowing it to focus on critical clinical trials.

CYBN

1 minute read

Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind

By Lara Goldstein

February 22, 2:43 PM

Specialty R&D psychedelics company PharmaDrug Inc. (OTCQB: LMLLF) has inked a research collaboration agreement with PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate the delivery of DMT through PharmaTher's microneedle patch technology.

LMLLF